BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33603143)

  • 1. Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death.
    Rotbain EC; Niemann CU; Rostgaard K; da Cunha-Bang C; Hjalgrim H; Frederiksen H
    Leukemia; 2021 Sep; 35(9):2570-2580. PubMed ID: 33603143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival, causes of death, and the prognostic role of comorbidities in chronic lymphocytic leukemia in the pre-ibrutinib era: A population-based study.
    Steingrímsson V; Lund SH; Dickman PW; Weibull CE; Björkholm M; Landgren O; Kristinsson SY
    Eur J Haematol; 2022 Feb; 108(2):145-153. PubMed ID: 34714556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of older adults with chronic lymphocytic leukemia: A Surveillance, Epidemiology, and End Results-Medicare cohort study.
    Duchesneau ED; McNeill AM; Schary W; Pate V; Lund JL
    J Geriatr Oncol; 2023 Nov; 14(8):101602. PubMed ID: 37696241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study.
    Strati P; Parikh SA; Chaffee KG; Kay NE; Call TG; Achenbach SJ; Cerhan JR; Slager SL; Shanafelt TD
    Br J Haematol; 2017 Aug; 178(3):394-402. PubMed ID: 28580636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia.
    Vojdeman FJ; Van't Veer MB; Tjønnfjord GE; Itälä-Remes M; Kimby E; Polliack A; Wu KL; Doorduijn JK; Alemayehu WG; Wittebol S; Kozak T; Walewski J; Abrahamse-Testroote MC; van Oers MH; Geisler CH
    Leuk Lymphoma; 2017 Mar; 58(3):594-600. PubMed ID: 27484290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of chronic lymphocytic leukemia comorbidity index in a young population: a real-world evidence study of a national gulf region cohort.
    Alshemmari SH; AlSarraf A; Kaempf A; Danilov AV
    BMC Cancer; 2024 May; 24(1):584. PubMed ID: 38741031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comorbidities at Diagnosis, Survival, and Cause of Death in Patients with Chronic Lymphocytic Leukemia: A Population-Based Study.
    Villavicencio A; Solans M; Zacarías-Pons L; Vidal A; Puigdemont M; Roncero JM; Saez M; Marcos-Gragera R
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33467494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of type 2 diabetes on mortality, cause of death, and treatment in chronic lymphocytic leukemia.
    Rotbain EC; Allmer C; Rostgaard K; Andersen MA; Vainer N; da Cunha-Bang C; Parikh SA; Rabe KG; Hjalgrim H; Frederiksen H; Slager SL; Niemann CU
    Am J Hematol; 2023 Aug; 98(8):1236-1245. PubMed ID: 37212419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
    Huang SJ; Chan J; Bruyère H; Allan LL; Gerrie AS; Toze CL
    Leuk Res; 2019 Sep; 84():106193. PubMed ID: 31325731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial use before chronic lymphocytic leukemia: a retrospective cohort study.
    Andersen MA; Rostgaard K; Niemann CU; Hjalgrim H
    Leukemia; 2021 Mar; 35(3):747-751. PubMed ID: 32684631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of advanced leukemic stage and skin cancer tumor stage with poor skin cancer outcomes in patients with chronic lymphocytic leukemia.
    Velez NF; Karia PS; Vartanov AR; Davids MS; Brown JR; Schmults CD
    JAMA Dermatol; 2014 Mar; 150(3):280-7. PubMed ID: 24429548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.
    Gade IL; Riddersholm SJ; Christiansen I; Rewes A; Frederiksen M; Enggaard L; Poulsen CB; Bergmann OJ; Gillström DB; Pedersen RS; Nielsen L; Eriksen HH; Torp-Pedersen C; Kristensen SR; Severinsen MT
    Blood Adv; 2018 Nov; 2(21):3025-3034. PubMed ID: 30425066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia.
    Thurmes P; Call T; Slager S; Zent C; Jenkins G; Schwager S; Bowen D; Kay N; Shanafelt T
    Leuk Lymphoma; 2008 Jan; 49(1):49-56. PubMed ID: 18203011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose fludarabine and cyclophosphamide combined with rituximab in the first-line treatment of elderly/comorbid patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): long-term results of project Q-lite by the Czech CLL Study Group.
    Smolej L; Brychtová Y; Cmunt E; Doubek M; Špaček M; Belada D; Šimkovič M; Stejskal L; Zygulová I; Urbanová R; Brejcha M; Zuchnická J; Móciková H; Kozák T;
    Br J Haematol; 2021 May; 193(4):769-778. PubMed ID: 33618437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases.
    Mauro FR; Foa R; Giannarelli D; Cordone I; Crescenzi S; Pescarmona E; Sala R; Cerretti R; Mandelli F
    Blood; 1999 Jul; 94(2):448-54. PubMed ID: 10397712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia: planning for an aging population.
    Gribben JG
    Expert Rev Anticancer Ther; 2010 Sep; 10(9):1389-94. PubMed ID: 20836674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited value of routine follow-up visits in chronic lymphocytic leukemia managed initially by watch and wait: A North Denmark population-based study.
    Nørgaard CH; Søgaard NB; Biccler JL; Pilgaard L; Eskesen MH; Kjartansdottir TH; Bøgsted M; El-Galaly TC
    PLoS One; 2018; 13(12):e0208180. PubMed ID: 30589850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
    Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
    Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes Mellitus Is Associated with Inferior Prognosis in Patients with Chronic Lymphocytic Leukemia: A Propensity Score-Matched Analysis.
    Gao R; Man TS; Liang JH; Wang L; Zhu HY; Wu W; Fan L; Li JY; Yang T; Xu W
    Cancer Res Treat; 2020 Jan; 52(1):189-206. PubMed ID: 31291713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.